Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Appia Bio
Biotech
Cell therapy biotech Appia shuts down as funding runs dry
The preclinical company reached the cusp of filing an IND application before running out of cash.
Darren Incorvaia
Aug 25, 2025 5:55pm
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders
Aug 12, 2022 9:30am
Gilead's Kite inks up to $875M blood cancer pact with Appia Bio
Aug 5, 2021 11:25am
Appia Bio aims for new off-the-shelf CAR-T with $52M raise
May 11, 2021 5:15am
